4292 Live Notices for Germany Human Medicine Tenders
Showing 1 to 20
Pharmaceutical Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) Within The Framework Of Open-House Procedures
31 Jan 2025
07 Sep 2026Dynamic Procurement System For Pharmaceuticals
Pharmaceutical Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) Within The Framework Of Open-House Procedures
1,000 Plus 500 Combat Boots In 2 Lots According To Lb
Pharmaceutical Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) Within The Framework Of Open-House Procedures
Pharmaceutical Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) Within The Framework Of Open-House Procedures
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Emtricitabine, Rilpivirine And Tenofovir Disoproxil (Atc Code J05Ar08).
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Amifampridine (Atc Code: N07Xx05).
Dynamic Procurement System For Pharmaceuticals
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Nitisinone (Atc Code: A16Ax04).
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Of The Social Code Book V With The Active Ingredient Rivaroxaban In The Dosage Form Hkp
Distribution Of Medicines As Of July 1, 2025
Public Tender (Supply Service) Supply Of Vaccines And Medicines Supply Of Vaccines And Medicines, Framework Contract For 2 Years
Distribution Of Medicines As Of July 1, 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Beclometasone/Formoterol (Atc Code According To Who: R03Ak08)
Tenders by Country